FYP

ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

Find entries where: FYP

is present as a standalone ligand in 4 entries

Find related ligands:

Chemical Component Summary
Name	ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Synonyms	Flumazenil
Identifiers	ethyl 8-fluoranyl-5-methyl-6-oxidanylidene-4~{H}-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Formula	C₁₅ H₁₄ F N₃ O₃
Molecular Weight	303.288
Type	NON-POLYMER
Isomeric SMILES	CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F
InChI	InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3
InChIKey	OFBIFZUFASYYRE-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	0
Bond Count	38
Aromatic Bond Count	11

Drug Info: DrugBank

DrugBank ID	DB01205
Name	Flumazenil
Groups	approved
Description	Fumazenil is an imidazobenzodiazepine derivative and a potent benzodiazepine receptor antagonist that competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex, thereby reversing the effects of benzodiazepine on the central nervous system.
Synonyms	Flumazenil Flumazenilum Flumazenilo Flumazepil
Brand Names	Flumazenil Flumazenil Injection, USP Flumazenil Injection Anexate Inj 0.1mg/ml Flumazenil Injection Sdz Jamp-flumazenil Romazicon
Indication	For the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, and where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures. Also for the management of benzodiazepine overdose as an adjunct for appropriate supportive and symptomatic measures.
Categories	Antidotes Benzazepines Benzodiazepine Antagonist Benzodiazepinones Compounds used in a research, industrial, or household setting Drugs that are Mainly Renally Excreted GABA Agents GABA Modulators Heterocyclic Compounds, Fused-Ring Miscellaneous Central Nervous System Agents Neurotransmitter Agents Protective Agents
ATC-Code	V03AB25
CAS number	78755-81-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Gamma-aminobutyric acid receptor subunit gamma-2	MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYA...	unknown	antagonist
Gamma-aminobutyric acid receptor subunit alpha-5	MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFT...	unknown	antagonist
GABA(A) Receptor	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	positive allosteric modulator
Gamma-aminobutyric acid receptor subunit alpha-1	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	antagonist

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682